Inventor
HONG SUN WOO
KR12 patents
Patents
12 patentsUS10125362B2Nov 13, 2018
RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
OLIX PHARMACEUTICALS INC9 citations82
US10064801B2Sep 4, 2018
RNA complexes that inhibit melanin production
OLIX PHARMACEUTICALS INC8 citations81
US10358648B2Jul 23, 2019
Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
OLIX PHARMACEUTICALS INC8 citations80
US10059949B2Aug 28, 2018
Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
OLIX PHARMACEUTICALS INC8 citations80
US10883105B2Jan 5, 2021
RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
OLIX PHARMACEUTICALS INC0 citations60
US10947541B2Mar 16, 2021
Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
OLIX PHARMACEUTICALS INC0 citations59
US11118184B2Sep 14, 2021
Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene
OLIX PHARMACEUTICALS INC0 citations58
US10301628B2May 28, 2019
Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
OLIX PHARMACEUTICALS INC1 citations58
US10512600B2Dec 24, 2019
RNA complexes that inhibit melanin production
OLIX PHARMACEUTICALS INC0 citations49
US10590423B2Mar 17, 2020
Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3
OLIX PHARMACEUTICALS INC0 citations48
US10829761B2Nov 10, 2020
Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
OLIX PHARMACEUTICALS INC0 citations47
US10519449B2Dec 31, 2019
Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB
OLIX PHARMACEUTICALS INC0 citations47